STK17A (DRAK1) at the crossroads of apoptosis, immunity, and cancer: Emerging roles and therapeutic opportunities. - Gonçalves LCP; Rastoin O; Morozova V; Buzet C; Bennetot A; Pagès G; Ronco C; Dufies M (Theranostics, 2026)